21/05/2026
Your prostate changes as you age — it's one of the few organs that keeps growing throughout your life. By your 50s, about half of men have benign prostatic hyperplasia (BPH), and that number climbs with each decade. Most of the time it's harmless, but without a baseline, it's hard to tell what's routine and what deserves a closer look.
That's where simple tools come in. A single PSA blood test in your 40s or 50s establishes a reference point — and research shows that midlife baseline PSA is one of the strongest predictors of future prostate cancer risk. It's not about one number being "good" or "bad" — it's about tracking how it changes over time.
When further investigation is needed, multiparametric MRI has changed the game. The PROMIS trial found it detects clinically significant cancer with 93% sensitivity, and the PRECISION trial showed MRI-guided biopsies catch more meaningful cancers while flagging fewer insignificant ones. That means fewer unnecessary procedures and better answers.
PSA tracking, imaging, and regular check-ins aren't about looking for problems — they're about staying informed. And when you're informed, you're in control.
Learn more on our blog → aheadhealth.com/de/insights/prostate-cancer-symptoms-screening-and-early-detection
Sources: Berry et al., J Urol 1984 · Ye et al., BMC Urol 2024 · Cirulli et al., Cancer 2024 · Schröder et al., Eur Urol 2008 · Ahmed et al. (PROMIS), Lancet 2017 · Kasivisvanathan et al. (PRECISION), NEJM 2018